Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis (Feb 2021).

Feb 22

Article Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8083972/

Journal: American Journal of Physiology Renal Physiology

Authors and Affiliations: Francesca Bruno 1, Joshua DeAguero 2,✉, Catherine Do 2,3, Doug Yoon Lee 4, Chunyan Tan 4, G Patricia Escobar 2,3, Brent Wagner 2,3

1Eboli Hospital “Maria SS Addolorata,” UOC of Nephrology and Dialysis, Eboli, Italy

2Kidney Institute of New Mexico, University of New Mexico Health Science Center, Albuquerque, New Mexico

3New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico

4University of Texas Health System, San Antonio, Texas

Bridget Belo

Toxicity associated with gadolinium-based contrast-enhanced examinations (May 2021).

Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: The Physio-Pathological Conditions for the Perfect Murder (2021).

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com

Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.